Vesilute 20 mg

Technical Details

Dosage & Usage Guidelines

In research settings, Vesilute is typically dosed at 10–20 mg per week, administered subcutaneously in 2–3 injections per week. Research duration may vary from 2 to 6 weeks depending on tissue regeneration goals and study design. The peptide is non-hormonal and acts through localized gene expression influence.

Suggested Peptide Combinations for Research

To expand the regenerative potential of Vesilute, researchers often combine it with other tissue- or neuro-supportive peptides:

• BPC-157 – promotes tissue healing and anti-inflammatory action
• GHK-Cu – supports angiogenesis and connective tissue repair
• Selank – for neuroimmune support in pelvic floor and urogenital studies
• Thymalin – immune-endocrine balance and systemic peptide support
• AOD 9604 – supports metabolic recovery and organ peptide synergy

Safety Profile

Vesilute has demonstrated excellent safety in preclinical research. It does not interfere with hormonal pathways, nor does it cause hepatotoxicity or cardiovascular stress. Being an organ-targeted bioregulator, it is systemically neutral and has no androgenic or estrogenic effects. It is designated for laboratory research use only and is not approved for human use.

USA Domestic Shipping | GMP Quality

Peptide Hubs ensures rapid and secure USA domestic shipping of Vesilute 20 mg and all bioregulator peptides. Each batch is produced under strict GMP standards. For researchers investigating bladder health, urothelial repair, or age-related urinary issues, Vesilute is a well-supported addition to the peptide toolkit.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions